Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
8
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
U.S. Energy
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Kevin Dome Production Will Benefit From Rising Global Energy Demand
Key Takeaways Vertical integration, new technologies, and strong reserves position U.S. Energy for structurally higher margins and upside from global energy demand shifts. Conservative market expectations overlook the company's earnings potential from infrastructure expansion, cash-rich operations, and strategic acquisition opportunities.
View narrative
US$3.50
FV
65.7% undervalued
intrinsic discount
29.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Owlet
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Connected Health Trends Will Drive Global Infant Monitoring Expansion
Key Takeaways Explosive international growth and strong adoption position Owlet as the leading brand in connected baby monitoring, with substantial potential for outsized revenue and margin expansion. Advanced tech, hospital integration, and premium services could drive high-margin B2B revenue streams and unlock major long-term value from both consumers and healthcare partners.
View narrative
US$15.00
FV
45.9% undervalued
intrinsic discount
21.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Rockwell Medical
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Aging And Home Care Trends Will Raise Demand Amid Risks
Key Takeaways Strong customer diversification, expanding industry contracts, and competitive gains are poised to drive above-expected revenue growth and significant margin expansion. Leading market position and scalable logistics infrastructure position Rockwell to benefit from industry shifts and unlock recurring, higher-margin future revenue streams.
View narrative
US$5.00
FV
79.0% undervalued
intrinsic discount
-13.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Clearside Biomedical
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Aging Global Population Will Boost Ocular Treatment Adoption
Key Takeaways Leading drug delivery technology, strong clinical results, and global partnerships could drive rapid adoption, robust licensing income, and significant revenue and margin expansion. Diversified pipeline and growing disease prevalence ensure long-term product launches, revenue diversification, and strong potential for transformative partnerships with next-generation therapy developers.
View narrative
US$6.00
FV
92.9% undervalued
intrinsic discount
112.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Hyperfine
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Global Aging And Telemedicine Will Drive Portable MRI Adoption
Key Takeaways Rapid clinical adoption, global expansion, and unique use-cases position Swoop for outsized revenue growth and transformative market share gains over traditional MRI. Strong network effects, recurring high-margin revenue, and scalable operations suggest substantial improvement in operating margins and long-term profitability.
View narrative
US$1.50
FV
14.0% undervalued
intrinsic discount
25.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Cibus
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Gene Editing And Climate Resilience Will Redefine Crop Development
Key Takeaways Near-global regulatory harmonization and RTDS platform adoption could rapidly accelerate Cibus' market reach, platform dominance, and recurring margin expansion beyond current analyst expectations. Diversification into sustainable ingredients and gene-editing positions Cibus for strong, stable growth through new high-value partnerships and above-industry-average royalty revenues.
View narrative
US$25.00
FV
94.4% undervalued
intrinsic discount
230.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
LARK Distilling
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Global Premiumization And Destination Tourism Will Spark Lasting Demand
Key Takeaways Transformational brand repositioning, global expansion, and deep inventory could unlock outsized growth and premium brand equity ahead of market expectations. Experiential tourism and innovative product development are poised to drive high-margin direct sales and lasting appeal among younger consumers.
View narrative
AU$3.30
FV
77.0% undervalued
intrinsic discount
35.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Offerpad Solutions
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Digital Transformation And Urbanization Will Boost Online Home Transactions
Key Takeaways Scalable, tech-driven offerings and a seamless hybrid model position Offerpad for accelerated revenue growth and industry-leading margin expansion as digital adoption in real estate rises. Cross-sell opportunities and enhanced liquidity enable Offerpad to capture a larger share of the transaction value chain and pursue aggressive market expansion with reduced risk.
View narrative
US$1.40
FV
5.0% overvalued
intrinsic discount
33.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Rani Therapeutics Holdings
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Needle-Free Oral Biologics Will Serve Aging Global Demand
Key Takeaways Rani's oral therapy platform offers a significant adoption advantage and margin potential due to its non-invasive delivery and superior performance versus injections. Advancements in manufacturing and partnerships position the company for strong long-term growth while reducing reliance on dilutive financing.
View narrative
US$12.00
FV
95.4% undervalued
intrinsic discount
283.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies